ArticleCancer management and research2025

Assessment of CD20 Marker as a Prognostic Predictor for Patients with Classical Hodgkin Lymphoma.

Eman Atarji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.